Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2

Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs f...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 95; no. 5; pp. e28788 - n/a
Main Authors Sakai‐Tagawa, Yuko, Yamayoshi, Seiya, Halfmann, Peter J., Wilson, Nancy, Bobholz, Max, Vuyk, William C., Wei, Wanting, Ries, Hunter, O'Connor, David H., Friedrich, Thomas C., Sordillo, Emilia M., Bakel, Harm, Simon, Viviana, Kawaoka, Yoshihiro
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID‐19 are based on antibody detection of the SARS‐CoV‐2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS‐CoV‐2 N showed the highest sensitivity followed by Inspecter KOWA SARS‐CoV‐2 and V Trust SARS‐CoV‐2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus.
AbstractList Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self-testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID-19 are based on antibody detection of the SARS-CoV-2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS-CoV-2 N showed the highest sensitivity followed by Inspecter KOWA SARS-CoV-2 and V Trust SARS-CoV-2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus.Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self-testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID-19 are based on antibody detection of the SARS-CoV-2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS-CoV-2 N showed the highest sensitivity followed by Inspecter KOWA SARS-CoV-2 and V Trust SARS-CoV-2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus.
Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID‐19 are based on antibody detection of the SARS‐CoV‐2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS‐CoV‐2 N showed the highest sensitivity followed by Inspecter KOWA SARS‐CoV‐2 and V Trust SARS‐CoV‐2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus.
Author Sakai‐Tagawa, Yuko
Bobholz, Max
Wei, Wanting
Yamayoshi, Seiya
Halfmann, Peter J.
Bakel, Harm
Sordillo, Emilia M.
Ries, Hunter
Kawaoka, Yoshihiro
Wilson, Nancy
O'Connor, David H.
Vuyk, William C.
Friedrich, Thomas C.
Simon, Viviana
Author_xml – sequence: 1
  givenname: Yuko
  surname: Sakai‐Tagawa
  fullname: Sakai‐Tagawa, Yuko
  organization: University of Tokyo
– sequence: 2
  givenname: Seiya
  orcidid: 0000-0001-7768-5157
  surname: Yamayoshi
  fullname: Yamayoshi, Seiya
  email: yamayo@ims.u-tokyo.ac.jp
  organization: National Center for Global Health and Medicine Research Institute
– sequence: 3
  givenname: Peter J.
  surname: Halfmann
  fullname: Halfmann, Peter J.
  organization: University of Wisconsin‐Madison
– sequence: 4
  givenname: Nancy
  surname: Wilson
  fullname: Wilson, Nancy
  organization: University of Wisconsin
– sequence: 5
  givenname: Max
  surname: Bobholz
  fullname: Bobholz, Max
  organization: University of Wisconsin
– sequence: 6
  givenname: William C.
  surname: Vuyk
  fullname: Vuyk, William C.
  organization: University of Wisconsin
– sequence: 7
  givenname: Wanting
  surname: Wei
  fullname: Wei, Wanting
  organization: University of Wisconsin‐Madison
– sequence: 8
  givenname: Hunter
  surname: Ries
  fullname: Ries, Hunter
  organization: University of Wisconsin‐Madison
– sequence: 9
  givenname: David H.
  surname: O'Connor
  fullname: O'Connor, David H.
  organization: University of Wisconsin
– sequence: 10
  givenname: Thomas C.
  surname: Friedrich
  fullname: Friedrich, Thomas C.
  organization: University of Wisconsin
– sequence: 11
  givenname: Emilia M.
  surname: Sordillo
  fullname: Sordillo, Emilia M.
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 12
  givenname: Harm
  surname: Bakel
  fullname: Bakel, Harm
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 13
  givenname: Viviana
  surname: Simon
  fullname: Simon, Viviana
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 14
  givenname: Yoshihiro
  surname: Kawaoka
  fullname: Kawaoka, Yoshihiro
  email: yoshihiro.kawaoka@wisc.edu
  organization: The University of Tokyo Pandemic Preparedness
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37212288$$D View this record in MEDLINE/PubMed
BookMark eNp90b1OwzAQB3ALgaAFBl4ARWKBIXB2ncQeUcWnipAosEZO7CBXiV3spKgbj8Az8iS4tDBUAg_n5Xen0_37aNNYoxA6wHCKAcjZpJmdEpYxtoF6GHgac8jwJuoBpmmcpjjZQX3vJwDAOCHbaGeQEUwIYz00Givjdatnup1HtoqcmGoZCdPqF2WiVvnWR5V10X2jS2dN5LtiJpwOwC_4-Pxh_Pn-MbTPoZI9tFWJ2qv91b-Lni4vHofX8ej-6mZ4PopLmlAWU5UBKyVISiuS0oIzroTMBBMKAMOApRykxEWZEpYwmkmeKlUmBCQfVLioBrvoeDl36uxrF3bMG-1LVdfCKNv5nDCchUcAB3q0Rie2cyZst1A8oZTQhTpcqa5olMynTjfCzfOfOwVwsgThCN47Vf0SDPkigzxkkH9nEOzZmi11K1ptTeuErv_reNO1mv89Or-9e152fAFYdpfN
CitedBy_id crossref_primary_10_1371_journal_pone_0289990
crossref_primary_10_1186_s12879_024_09408_8
crossref_primary_10_11124_JBIES_23_00291
crossref_primary_10_1016_j_heliyon_2024_e29937
crossref_primary_10_1128_spectrum_01768_23
crossref_primary_10_1002_jmv_29361
Cites_doi 10.1007/s00430-022-00752-7
10.1016/j.jviromet.2020.114024
10.3390/v14040654
10.1128/spectrum.02286-22
10.1007/s00430-021-00719-0
10.1016/j.jcv.2020.104472
10.1128/JCM.01438-20
10.1128/JCM.00977-20
10.1002/jmv.27908
10.1371/journal.pone.0239403
10.1016/j.jiac.2021.01.007
10.3390/life12111941
10.1007/s00430-022-00730-z
10.1001/jamanetworkopen.2022.35844
10.1016/j.ijid.2020.05.098
10.1001/jama.2020.8259
10.1016/j.jcv.2020.104455
10.3390/v13112183
10.3389/fmed.2020.00225
10.2147/IJGM.S297762
10.1016/j.jcv.2020.104712
10.1016/j.jcv.2022.105119
10.1128/spectrum.01922-22
10.1016/j.jcv.2020.104500
10.3390/v12121420
ContentType Journal Article
Copyright 2023 The Authors. published by Wiley Periodicals LLC.
2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.
2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by Wiley Periodicals LLC.
– notice: 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
DOI 10.1002/jmv.28788
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Genetics Abstracts
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9071
EndPage n/a
ExternalDocumentID 37212288
10_1002_jmv_28788
JMV28788
Genre shortCommunication
Research Support, U.S. Gov't, P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Centers for Disease Control and Prevention
– fundername: Japan Agency for Medical Research and Development
– fundername: State of Wisconsin Department of Health Services project
– fundername: National Institutes of Allergy and Infectious Diseases Center for Research
– fundername: CDC HHS
– fundername: NIH HHS
  grantid: S10 OD030463
– fundername: NIH HHS
  grantid: S10 OD026880
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AI.
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECGQY
EJD
ELTNK
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V2E
VH1
W8V
W99
WBKPD
WHG
WIB
WIH
WIJ
WIK
WJL
WNSPC
WOHZO
WQJ
WXI
WXSBR
WYISQ
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
ID FETCH-LOGICAL-c4548-4e708cd0d44f264b989ead7a8ae001038690dd1bc6285847d96eec520d93f1bf3
IEDL.DBID DR2
ISSN 0146-6615
1096-9071
IngestDate Thu Jul 10 23:18:45 EDT 2025
Fri Jul 25 21:34:56 EDT 2025
Mon Jul 21 06:03:35 EDT 2025
Tue Jul 01 02:24:59 EDT 2025
Thu Apr 24 23:10:56 EDT 2025
Sun Jul 06 04:45:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords SARS-CoV-2
Sensitivity
Omicron
Rapid antigen test
Language English
License Attribution-NonCommercial
2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4548-4e708cd0d44f264b989ead7a8ae001038690dd1bc6285847d96eec520d93f1bf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7768-5157
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.28788
PMID 37212288
PQID 2819544241
PQPubID 105515
PageCount 6
ParticipantIDs proquest_miscellaneous_2817777201
proquest_journals_2819544241
pubmed_primary_37212288
crossref_primary_10_1002_jmv_28788
crossref_citationtrail_10_1002_jmv_28788
wiley_primary_10_1002_jmv_28788_JMV28788
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2023
2023-05-00
20230501
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: May 2023
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Journal of medical virology
PublicationTitleAlternate J Med Virol
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 14
2020; 7
2021; 13
2022; 211
2021; 27
2023; 11
2021; 288
2021; 134
2022; 5
2022; 94
2023; 212
2022; 12
2022; 14
2020; 15
2020; 58
2020; 129
2020; 12
2020; 323
2020; 99
2021; 210
2022; 10
2022; 148
e_1_2_9_11_1
e_1_2_9_10_1
e_1_2_9_13_1
e_1_2_9_12_1
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_16_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
References_xml – volume: 58
  issue: 9
  year: 2020
  article-title: Clinical evaluation of self‐collected saliva by quantitative reverse transcription‐PCR (RT‐qPCR), direct RT‐qPCR, reverse transcription‐loop‐mediated isothermal amplification, and a rapid antigen test to diagnose COVID‐19
  publication-title: J Clin Microbiol
– volume: 14
  issue: 4
  year: 2022
  article-title: Analytical sensitivity of six SARS‐CoV‐2 rapid antigen tests for omicron versus Delta variant
  publication-title: Viruses
– volume: 10
  issue: 5
  year: 2022
  article-title: Decreased sensitivity of rapid antigen test is associated with a lower viral load of omicron than delta SARS‐CoV‐2 variant
  publication-title: Microbiol Spectr
– volume: 323
  start-page: 2249
  issue: 22
  year: 2020
  end-page: 2251
  article-title: Interpreting diagnostic tests for SARS‐CoV‐2
  publication-title: JAMA
– volume: 27
  start-page: 800
  issue: 6
  year: 2021
  end-page: 807
  article-title: Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS‐CoV‐2 antigen
  publication-title: J Infect Chemother
– volume: 7
  year: 2020
  article-title: Development and potential usefulness of the COVID‐19 Ag Respi‐Strip diagnostic assay in a pandemic context
  publication-title: Front Med
– volume: 288
  year: 2021
  article-title: Comparison of the SARS‐CoV‐2 Rapid antigen test to the real star Sars‐CoV‐2 RT PCR kit
  publication-title: J Virol Methods
– volume: 148
  year: 2022
  article-title: Determining the reliability of rapid SARS‐CoV‐2 antigen detection in fully vaccinated individuals
  publication-title: J Clin Virol
– volume: 129
  year: 2020
  article-title: Implementation of rapid SARS‐CoV‐2 antigenic testing in a laboratory without access to molecular methods: experiences of a general hospital
  publication-title: J Clin Virol
– volume: 211
  start-page: 105
  issue: 2‐3
  year: 2022
  end-page: 117
  article-title: Impaired detection of omicron by SARS‐CoV‐2 rapid antigen tests
  publication-title: Med Microbiol Immunol
– volume: 99
  start-page: 328
  year: 2020
  end-page: 333
  article-title: Evaluation of a novel antigen‐based rapid detection test for the diagnosis of SARS‐CoV‐2 in respiratory samples
  publication-title: Int J Infect Dis
– volume: 134
  year: 2021
  article-title: Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS‐CoV‐2
  publication-title: J Clin Virol
– volume: 15
  issue: 9
  year: 2020
  article-title: Disentangling primer interactions improves SARS‐CoV‐2 genome sequencing by multiplex tiling PCR
  publication-title: PLoS One
– volume: 210
  start-page: 263
  year: 2021
  end-page: 275
  article-title: Comparison of four commercial, automated antigen tests to detect SARS‐CoV‐2 variants of concern
  publication-title: Med Microbiol Immunol
– volume: 129
  year: 2020
  article-title: Evaluation of rapid antigen test for detection of SARS‐CoV‐2 virus
  publication-title: J Clin Virol
– volume: 212
  start-page: 13
  issue: 1
  year: 2023
  end-page: 23
  article-title: Variable detection of Omicron‐BA.1 and ‐BA.2 by SARS‐CoV‐2 rapid antigen tests
  publication-title: Med Microbiol Immunol
– volume: 58
  issue: 8
  year: 2020
  article-title: Evaluation of a rapid diagnostic assay for detection of SARS‐CoV‐2 antigen in nasopharyngeal swabs
  publication-title: J Clin Microbiol
– volume: 14
  start-page: 435
  year: 2021
  end-page: 440
  article-title: Evaluation of analytical performance of seven rapid antigen detection kits for detection of SARS‐CoV‐2 virus
  publication-title: Int J Gen Med
– volume: 129
  year: 2020
  article-title: Low performance of rapid antigen detection test as frontline testing for COVID‐19 diagnosis
  publication-title: J Clin Virol
– volume: 13
  issue: 11
  year: 2021
  article-title: Comparative sensitivity of rapid antigen tests for the delta variant (B.1.617.2) of SARS‐CoV‐2
  publication-title: Viruses
– volume: 94
  start-page: 5033
  issue: 10
  year: 2022
  end-page: 5037
  article-title: Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS‐CoV‐2 Omicron variant BA.2 sublineage
  publication-title: J Med Virol
– volume: 12
  issue: 11
  year: 2022
  article-title: The performance of lateral flow tests in the age of the omicron: a rapid systematic review
  publication-title: Life
– volume: 11
  issue: 1
  year: 2023
  article-title: Performance evaluation of five rapid at‐home COVID‐19 antigen tests against the omicron variant
  publication-title: Microbiol Spectr
– volume: 12
  start-page: 1420
  issue: 12
  year: 2020
  article-title: Comparison of rapid antigen tests for COVID‐19
  publication-title: Viruses
– volume: 5
  issue: 10
  year: 2022
  article-title: COVID‐19 symptoms and duration of rapid antigen test positivity at a community testing and surveillance site during pre‐delta, delta, and omicron BA.1 periods
  publication-title: JAMA Netw Open
– ident: e_1_2_9_20_1
  doi: 10.1007/s00430-022-00752-7
– ident: e_1_2_9_12_1
  doi: 10.1016/j.jviromet.2020.114024
– ident: e_1_2_9_24_1
  doi: 10.3390/v14040654
– ident: e_1_2_9_22_1
  doi: 10.1128/spectrum.02286-22
– ident: e_1_2_9_15_1
  doi: 10.1007/s00430-021-00719-0
– ident: e_1_2_9_9_1
  doi: 10.1016/j.jcv.2020.104472
– ident: e_1_2_9_3_1
  doi: 10.1128/JCM.01438-20
– ident: e_1_2_9_5_1
  doi: 10.1128/JCM.00977-20
– ident: e_1_2_9_19_1
  doi: 10.1002/jmv.27908
– ident: e_1_2_9_26_1
  doi: 10.1371/journal.pone.0239403
– ident: e_1_2_9_13_1
  doi: 10.1016/j.jiac.2021.01.007
– ident: e_1_2_9_17_1
  doi: 10.3390/life12111941
– ident: e_1_2_9_21_1
  doi: 10.1007/s00430-022-00730-z
– ident: e_1_2_9_18_1
  doi: 10.1001/jamanetworkopen.2022.35844
– ident: e_1_2_9_6_1
  doi: 10.1016/j.ijid.2020.05.098
– ident: e_1_2_9_2_1
  doi: 10.1001/jama.2020.8259
– ident: e_1_2_9_7_1
  doi: 10.1016/j.jcv.2020.104455
– ident: e_1_2_9_16_1
  doi: 10.3390/v13112183
– ident: e_1_2_9_8_1
  doi: 10.3389/fmed.2020.00225
– ident: e_1_2_9_11_1
  doi: 10.2147/IJGM.S297762
– ident: e_1_2_9_14_1
  doi: 10.1016/j.jcv.2020.104712
– ident: e_1_2_9_23_1
  doi: 10.1016/j.jcv.2022.105119
– ident: e_1_2_9_25_1
  doi: 10.1128/spectrum.01922-22
– ident: e_1_2_9_4_1
  doi: 10.1016/j.jcv.2020.104500
– ident: e_1_2_9_10_1
  doi: 10.3390/v12121420
SSID ssj0008922
Score 2.4302537
Snippet Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e28788
SubjectTerms Amino acid sequence
Amino Acid Substitution
Amino acids
Antibodies
Antigens
Antiviral Agents
Antiviral drugs
COVID-19
COVID-19 - diagnosis
Humans
N protein
Omicron
Proteins
Rapid antigen test
Regulatory agencies
Saliva
SARS-CoV-2 - genetics
SARS‐CoV‐2
Sensitivity
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Virology
Viruses
Websites
Title Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.28788
https://www.ncbi.nlm.nih.gov/pubmed/37212288
https://www.proquest.com/docview/2819544241
https://www.proquest.com/docview/2817777201
Volume 95
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTtxAEC0RDiiXsCQhw6YOyoGLB7vd3sQJIRBCTIiYgDhEstyLpQDjQcwMB058At_Il1DVbRsBiYTwwbLkstvurV53Vb0C-METnSUyCL0iSLQnZMDJSGg8E-hCKRmXYUABzr2f8f6JODiLzqZgq4mFcfwQ7YYbjQw7X9MAL-Ro84k09Hxw00W4n1KgL_lqESA6fqKOSjNnQcCZwEMdFDWsQj7fbJ98roteAczneNUqnL1Z-NN8qvMzuehOxrKrbl-wOL7zX-bgUw1E2bbrOfMwZaoFmOnVpvbPcNgn13aXW4INS3ZdXP3VDNuB6DsZAtTxiCHgZUcDcumr2Ggib3DdTW41JN7fPu4_3N3vDE_xzL_Ayd7u7519r0694CkR0RajSfxUaV8LUSJkklmaYZdLirQwNjME5bHSOpCKIjBRweksNkZF3NdZWAayDL_CdDWszDdgKkPEFPgGsU4sigjfwP20TFUscKWCAKcDG00j5KrmJaf0GJe5Y1TmOdZObmunA-ut6JUj4_iX0ErTknk9Hke5NRcKgXClA9_b2ziSyDxSVGY4sTIJHoiIOrDoekBbSogLZc7p5Ru2Hf9ffH7QO7UXS28XXYaPlMXe-VGuwPT4emJWEeuM5Rp84OLXmu3aj9gw-wA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RKrW9QN8s0NatWolLdhPHeR16QFC0wC6VWHa1txA_IpVHFrG7IDjxE_gh_JX-if6Sju0kiD6kXjg0hyhKRnZiz4y_2ONvAD7SSCYR93wn8yLpMO5RvUioHOXJTAge5r6nNzh3d8J2n20Ng-EM3FR7YSw_RD3hpi3D-Gtt4HpCunXLGnpwfNZEvB_HZUjltro4xx-28efNdezdT5RufNlbaztlTgFHsEDPnanIjYV0JWM5YgGexAm2ZZTFmTIpD3SCJik9LvTWQvTcMgmVEgF1ZeLnHs99LPcBPNQZxDVT__ruLVlVnNg1C_Q9Do56QcVj5NJW_ap3R7_fIO1dhGyGuI15-F41jo1sOWxOJ7wpLn_hjfxfWu8pzJVYm6xa43gGM6p4Do-6ZTTBC-j0dPS-TZ9BRjk5zU6-SYKqphlKCWLwyZggpidfj3XUYkHGU36WocEWeB_Fe6u7vR9X12ujAZ7pS-jfy7e8gtliVKgFICJBUOi5CuFcyLIAS6BunMciZPgzhhiuAStVr6eipF7XGUCOUksaTVPsjdT0RgM-1KInlm_kT0LLleqkpcsZp2ZFlDFEZA14Xz9GZ6FXgLJCjaZGJsIDQV8DXluVq2vxI0QxVBe-YhTn79WnW92BuVj8d9F38Li91-2knc2d7SV4QhEq2rDRZZidnE7VG4R2E_7WWBSB_ftWwp9--Fel
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT-QwDLZ4SIgLApaF4ZlFrMSl0Kbp68ABASNeA2gHELfSJqkEgs6ImQFx4yfwP_hX_BLstFOEFiQu9FBVqpVEdux8iR0bYIUHKgpSx7USJ1CWSB1OTkJtaUclUqZ-5jp0wblx5O-eif0L72IAXvp3YYr8ENWBG2mGsdek4G2Vrb8nDb2-vV9DuB-GZUTlgX58wP1aZ2NvG4X7l_P6zunWrlWWFLCk8OjoTAd2KJWthMgQCqRRGCErgyRMtKl4QPWZlHJSSTcL0XCryNdaetxWkZs5aeZiu4MwTM5Fih_j4qQy-2FUuCzQ9Fi46Hn9NEY2X6-G-nHx-w_RfgTIZoWrj8NYCU3ZZjGXJmBA55Mw0iid77_gsEnB7kW1CdbK2F3SvlIMJUMJPRlC1m6HIQRmx7cU5JezTi-9x504BdoQeXPzX_P16XmrdY5vPgVnP8K53zCUt3I9A0xGiKEcWyP68UXiYQvcDrNQ-shWgqc1WO1zKZZlpnIqmHETFzmWeYwMjQ1Da7BckbaL9ByfEc33WR2XGtqJjQNRCAQwNfhT_UbdIodJkutWz9AE-CBGqsF0IaKqFxe3zpxT46tGZl93H-83zs3H7PdJl2DkZLseH-4dHczBKJW4L4Is52Goe9fTCwiEuumimYAMLn96xr8By0QWLA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sensitivity+of+rapid+antigen+tests+for+Omicron+subvariants+of+SARS%E2%80%90CoV%E2%80%902&rft.jtitle=Journal+of+medical+virology&rft.au=Yuko+Sakai%E2%80%90Tagawa&rft.au=Yamayoshi%2C+Seiya&rft.au=Halfmann%2C+Peter+J&rft.au=Wilson%2C+Nancy&rft.date=2023-05-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0146-6615&rft.eissn=1096-9071&rft.volume=95&rft.issue=5&rft_id=info:doi/10.1002%2Fjmv.28788&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon